|
![]() |
PulmicortThis page contains recent news articles, when available, and an overview of Pulmicort but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Pulmicort (when available) Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease. Mechanism Of Action: The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. News Articles on Budesonide Budesonide Poses No Risk in COPD - Aug 28, 2009 Pooled data from seven large prospective trials show that inhaled budesonide (Pulmicort) does not increase COPD MedPage Today New Report Just Published Stakeholder Insight: Asthma - Over ... - Aug 5, 2009 The traditional products Flixotide/Flovent (fluticasone) and Pulmicort (budesonide) scored consistently higher than the novel products Asmanex (mometasone) Live-PR.com (Pressemitteilung) AstraZeneca plc - Jul 13, 2009 ...cancer therapy Arimidex, cholesterol reducer Crestor, acid reflux remedy Nexium, Seroquel for schizophrenia and Symbicort and Pulmicort for asthma. Fresh Business Thinking AstraZeneca pulls out of asthma drug pact with MAP - Jul 10, 2009 Phase III clinical trial of unit dose budesonide (UDB), the active ingredient found in AstraZeneca's Pulmicort, did not meet its primary endpoints. Pharma Times Watson Pharmaceuticals to purchase Arrow Group - Jun 18, 2009 ...a generic version of the blood pressure drug Altace and is among the generic drug makers challenging AstraZeneca's patent on the asthma drug Pulmicort. The Star-Ledger - NJ.com AstraZeneca's Pipeline Must Deliver - Jun 29, 2009 The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Seeking Alpha DotW: Singing in the Rain - Jul 10, 2009 Thinking the MAP drug could extend its own budesonide franchise, Pulmicort Respules, the Big Pharma ponied up $40 million upfront and promised biobucks in The IN VIVO Blog Drug-induced diarrhea proved fatal to woman - Jul 6, 2009 Other inhaled steroids include AeroBid, Asmanex, Azmacort, Pulmicort, QVAR and Symbicort. I had excellent seizure control with Keppra. Online Athens Zacks Analyst Blog Highlights: AstraZeneca, Darden Restaurants ... - Jun 29, 2009 The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Earthtimes (press release) ØÙŠØ§Ø© صغيري مرهونة بعطÙ?كم - Jul 4, 2009 لي بها، ØÙŠØ« انني عاطل عن العمل، وطÙ?لي Ø¨ØØ§Ø¬Ø© إلى ادوية لا تصرÙ? الا للكويتيين- علبة دواء أسبوعيا- Pulmicort- ربع ميلليغرام وهو خاص بالربو وقيمته21دينارا. القبس Inhalasjonssteroider og pÃ¥virkning pÃ¥ tenner. - Jun 22, 2009 Allmennlege har en pasient med KOLS som bruker budesonid (Pulmicort turbuhaler). Pasienten har nÃ¥ problemer med at tennene løsner, og har hørt fra tannlegen RELIS טבע ×”×’×™×¢×” להסכ×? ×¢×? ×’'×•× ×¡×•×Ÿ ×?× ×“ ×’'×•× ×¡×•×Ÿ על הפסקת השיווק של גלולה ... - Jul 7, 2009 ...מהלך כמעט ×–×”×” עשתה טבע ×‘× ×•×‘×ž×‘×¨ 2008 ×›×?שר שיווקה גרסה ×’× ×¨×™×ª של התרופה Pulmicort לטיפול ב×?סתמה שמכירותיה מילי×?רד דולר. שיווק התרופה הופסק יומיי×? ×?חר כך בעקבות The Marker AstraZeneca: Apotex Barred From Launching Pulmicort Respules - Apr 16, 2009 ...from launching a generic version of its PULMICORT RESPULES until further order of the court. On Apr. 27, the court will commence a hearing to determine Wall Street Journal AstraZeneca files lawsuit against Apotex over asthma drug - Apr 7, 2009 AstraZeneca has begun legal proceedings against Aptoex seeking a declaration of patent infringement regarding its asthma treatment, Pulmicort respules. Hays Pharma Apotex Wins Approval to Copy AstraZeneca’s Pulmicort - Apr 3, 2009 The approval surprised investors who thought the threat to Pulmicort had ended after AstraZeneca’s November settlement with Teva Pharmaceutical Industries Bloomberg AstraZeneca wins Pulmicort legal decision - Apr 18, 2009 By John O'Doherty AstraZeneca has won a legal battle in the US temporarily preventing the launch of a generic version of Pulmicort Respules, its childhood Financial Times Barclays and Lloyds climb ahead of Citigroup figures - Apr 17, 2009 Pharmaceuticals group AstraZeneca has slipped 13p to £23.82 despite announcing an interim court victory against a generic manufacturer of its pulmicort guardian.co.uk Business in the courts - Apr 12, 2009 AstraZeneca PLC asked a US court to stop generic-drug maker Apotex Inc. from selling copies of the asthma drug Pulmicort Respules. The News Journal MARKET COMMENT: London Stocks End Up On Citigroup, GE - Apr 17, 2009 New Jersey has granted its request for a temporary restraining order barring Apotex from launching a generic version of its Pulmicort Respules medicine. Wall Street Journal A Single Inhaler for Your Asthma - Apr 16, 2009 Most asthma patients use their maintenance asthma inhaler, most commonly an inhaled steroid like Pulmicort or Flovent, and a separate rescue inhaler like About - News & Issues More good news from the US has banks driving share market gains ... - Apr 17, 2009 ...granted a temporary restraining order barring Apotex from selling a generic version of AstraZeneca's lucrative Pulmicort Respules asthma medicine. Daily Mail AstraZeneca a Hold for Now - Apr 13, 2009 The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Zacks.com Analyses - AstraZeneca: Crédit Suisse à sous-pondérer - Apr 7, 2009 Pulmicort respules: Late on Friday FDA announced that Apotex has received US approval for generic Pulmicort respules. We understand (from AZN) that Apotex Bolsamania.fr Business news in brief - Apr 18, 2009 ...company's request for a temporary restraining order barring Apotex Inc. from launching a generic version of its Pulmicort respules, which treat asthma. Philadelphia Inquirer Woman robbed of asthma medication - Apr 6, 2009 Police said the purse contained Apo-Risperidone, Apo-Bromocriptine Mesylate, Pulmicort Turbuhaler Budesonide, an asthma puffer and Bricanyl puffer. Winnipeg Sun Mylan and Schering-Plough settle patent dispute - Apr 9, 2009 ...week commenced legal proceedings against Apotex over its application to market a generic version of the Anglo-Swiss firm's asthma treatment, Pulmicort. Hays Pharma Biotech/Pharma Docket - Apr 15, 2009 AstraZeneca originally filed suit on March 31, 2009, upon Apotex's announced intention to market a generic version of AstraZeneca's Pulmicort® Resulpules on Patent Docs AstraZeneca, Lloyds, RBS, Shell: UK, Irish Equity Preview - Apr 16, 2009 AstraZeneca Plc (AZN LN): The UK's second-largest drugmaker won a bid to temporarily block Apotex Inc. from selling copies of the asthma drug Pulmicort Bloomberg Tuesday's news and tips - Apr 7, 2009 AstraZeneca has filed a lawsuit in the US against Canadian firm Apotex in an attempt to try and stop it selling a generic version of Astra's Pulmicort Investors Chronicle Lloyds down on OFT news - Apr 7, 2009 AstraZeneca has filed a lawsuit in the US against Canadian firm Apotex in an attempt to try and stop it selling a generic version of Astra's Pulmicort Economy News Amgen to present preclinical oncology data; Analysts speculate on ... - Apr 17, 2009 A US court gave the drugmaker a restraining order that bars Apotex from selling a copycat version of AstraZeneca's top-selling asthma medicine Pulmicort FierceBiotech Market Report -- In Play () - Apr 17, 2009 ...for a temporary restraining order, barring Apotex from launching a generic version of AstraZeneca's PULMICORT RESPULES until further order of the court. MSN Money * Vodafone, BT gain on positive broker notes * Defensive tobacco ... - Apr 17, 2009 Thursday granted a temporary restraining order barring Apotex from selling a generic version of AstraZeneca's lucrative Pulmicort Respules asthma medicine. guardian.co.uk astrazeneca: Court Grants Restraining Order Against Apotex - Apr 17, 2009 ...of New Jersey granted its request for a temporary restraining order barring Apotex from launching a generic version of its Pulmicort Respules medicine. FOXBusiness Friday's news and tips - Apr 17, 2009 Canadian generic drug specialist Apotex from launching a generic version of drug giant AstraZeneca's asthma treatment for children Pulmicort Respules. Investors Chronicle Broker tips: BT, Tesco, AstraZeneca - Apr 17, 2009 ...drug giant AstraZeneca's asthma treatment for children Pulmicort Respules, prompting Panmure Gordon to reiterate its recommendation to buy the shares. ShareCast Markets: FTSE 100 finishes on a high - Apr 17, 2009 09:44 - The world's second largest drugmaker, astrazeneca (AZN), has won a temporary block on Apotex's selling of the asthma drug Pulmicort Respules. Interactive Investor AstraZeneca Files Lawsuit Against Apotex - Apr 7, 2009 The lawsuit follows Apotex's indication of intent to market a generic version of AstraZeneca's Pulmicort Respules in the US prior to the expiration of FOXBusiness CORRECT: EARNINGS PREVIEW: European Drug Cos' 1Q - Apr 9, 2009 ...is unable to prevent Canadian generics drugmaker Apotex from launching its cheaper version of children's asthma treatment Pulmicort Respules. EasyBourse.com Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc ... - Apr 14, 2009 The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Business Wire (press release) Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc ... - Apr 14, 2009 The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Trading Markets (press release) AstraZeneca erringt Etappensieg im Patentstreit mit Apotex - Apr 17, 2009 Der Wettbewerber darf somit seine generische Version von Pulmicort Respules in den USA zunächst nicht vermarkten. Pulmicort Respules ist ein Medikament zur Frankfurter Allgemeine Zeitung AstraZeneca: un générique d'Apotex temporairement interdit. - Apr 17, 2009 AstraZeneca avait déposé une plainte aux Etats-Unis en mars contre la société Apotex, l'accusant de violation de brevet de Pulmicort Respules. Cercle Finance Astras Pulmicort möter generikakonkurrens - Apr 3, 2009 ..."Efter att Apotex nu oväntat fÃ¥tt ett fullt godkännande, och om bolaget beslutar sig för att pÃ¥börja försäljningen snart, sÃ¥ kan vÃ¥ra nuvarande estimat för Dagens Industri 花旗和GE财报超预期 英股高收1% - Apr 17, 2009 ...阿斯利康指出,美国新泽西地方法院已å?Œæ„?自己的一项请求,暂时é™?制Apotex推出è?¯ç‰©Pulmicort Respules的仿制å“?。这ç§?è?¯ç‰©æ˜¯é˜¿æ–¯åˆ©åº·çš„一个é‡?è¦?产å“?。 新浪网 Astra Zeneca fÃ¥r stopp pÃ¥ kopierad astmamedicin - Apr 16, 2009 I fjol uppgick Astra Zenecas försäljning av Pulmicort till 982 miljoner dollar. Försäljningen av Respules-versionen stod för 90 procent av Dagens Industri AstraZeneca: la FDA demande plus d'informations sur Symbicort - Apr 6, 2009 LONDRES (Dow Jones)--AstraZeneca PLC (AZN) a fait savoir lundi que l'autorité sanitaire américaine, la Food and Drug Administration, lui avait demandé des EasyBourse.com AstraZeneca resta in rosso nonostante giudizio favorevole Corte USA - Apr 17, 2009 Distretto del New Jersey ha acconsentito alla sua richiesta di bloccare il lancio di una versione generica del suo farmaco Pulmicort da parte di Apotex. La Repubblica ÜBERBLICK/Unternehmen - 11.30 Uhr-Fassung - Apr 7, 2009 AstraZeneca wirft Apotex vor, vor dem Auslaufen des Patentschutzes eine generische Version des Asthmamedikaments Pulmicort Respules in den USA vermarkten zu Frankfurter Allgemeine Zeitung Domstol beviljar AstraZenecas begäran om tillfälligt ... - Apr 16, 2009 ...lanserar en generisk version av AstraZenecas PULMICORT RESPULES (budesonid inhalationssuspension) tills domstolen ger ytterligare besked. Newsdesk (pressmeddelande) Terugroepactie Nebuhaler - Apr 17, 2009 Nebuhaler is een inhalatie hulpmiddel bedoeld voor het gebruik in combinatie met AstraZeneca's dosis aërosol Pulmicort (budesonide). apothekersnieuws.nl 미 법ì›?, '풀미코트 ë ˆìŠ¤í“°' ìƒ?ì‚° 금지 ëª…ë ¹ - Apr 16, 2009 ...ë¯¸êµ ë²•ì›?ì?€ ì•„í?¬í…?스사가 ‘풀미코트 ë ˆìŠ¤í“°(Pulmicort Respules)'ì?˜ ì œë„¤ë¦ì?„ ìƒ?산하는 것ì?„ ì œí•œí•˜ëŠ” 한시ì ? ê¸ˆì§€ëª…ë ¹ì?„ ë‚´ë¦°ë‹¤ê³ 18ì?¼ ë°?혔다. 데일리팜 AstraZeneca verklagt Apotex wegen Patentverletzung - Apr 7, 2009 AstraZeneca wirft Apotex vor, vor dem Auslaufen des Patentschutzes eine generische Version des Asthmamedikaments Pulmicort Respules in den USA vermarkten zu Frankfurter Allgemeine Zeitung AKTIEN EUROPA/Sehr fest - Gewinne in USA und Japan - Optimismus - Apr 6, 2009 Der britische Pharmakonzern will den Verkauf einer generischen Version seines Asthmamittels "Pulmicort Respules" juristisch verhindern. NZZ Online Astra Zeneca stämmer generikatillverkare - Apr 6, 2009 ..."Astra Zeneca har fullt förtroende för de immateriella rättigheter som skyddar Pulmicort Respules och kommer att med kraft försvara dem", Dagens Industri 法院批准AstraZeneca所æ??å?‘出临时ç¦?æ¢ä»¤çš„请求 - Apr 17, 2009 ...纽泽西州地方法院批准AstraZeneca (AZN)æ??出法院å?‘出临时ç¦?æ¢ä»¤çš„请求,ç¦?æ¢Apotex推出AstraZenecaçš„PULMICORT RESPULESå¦å??版,ç‰å¾…法院å?‘布进一æ¥å‘½ä»¤ï¼Œ4月27日, 凤凰网 Asthme : rappel des chambres d’inhalation Nes Spacer® AstraZeneca - Apr 6, 2009 Celles-ci sont utilisées pour administrer la spécialité Pulmicort® à des enfants asthmatiques. « Depuis décembre 2008, quatre incidents survenus chez des Destination Santé æ°£ç®¡è—¥å®¹å™¨å®‰è£?出錯需è¦?回收 - Mar 31, 2009 ...è—¥å» è¡¨ç¤ºï¼Œæœ‰é—œå„€å™¨éœ€é…?å?ˆæ——下的壓縮å?¸å…¥å™¨ã€ŒPulmicortã€?使用,去年在本港售出的數é‡?ä¸?足二百個,主è¦?經醫生æ??供給病人使用,公立醫院涉å?Šå…©ã€?三個。 大公報 Opel-Mutter GM schließt Insolvenz nicht aus - Apr 5, 2009 ...(dpa-AFX) Der britische Pharmakonzern AstraZeneca will den Verkauf einer generischen Version seines Asthmamittels „Pulmicort Respules“ juristisch verhindern Frankfurter Allgemeine Zeitung ÜBERBLICK/Unternehmen 11.30 Uhr-Fassung - Apr 17, 2009 Der Wettbewerber darf somit seine generische Version von Pulmicort Respules in den USA zunächst nicht vermarkten. Die 19 großen US-Banken werden infolge der Frankfurter Allgemeine Zeitung 花旗和GEè²¡å ±è¶…é ?期 英股高收1% - Apr 17, 2009 ...阿斯利康指出,美國新澤西地方法院已å?Œæ„?è‡ªå·±çš„ä¸€é …è«‹æ±‚ï¼Œæš«æ™‚é™?制Apotex推出藥物Pulmicort Respules的仿製å“?。這種藥物是阿斯利康的一個é‡?è¦?產å“?。 新浪網 Brand Names/Synonyms: Pulmicort is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon Drug Category: Pulmicort is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 Dosage Forms: CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION Absorption: Complete Interactions: Interactions for Budesonide: Concomitant oral administration of ketoconazole (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral budesonide. If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered. After extensive intake of grapefruit juice (which inhibits CYP3A4 activity predominantly in the intestinal mucosa), the systemic exposure for oral budesonide increased about two times. As with other drugs primarily being metabolized through CYP3A4, ingestion of grapefruit or grapefruit juice should be avoided in connection with budesonide administration. Chemical IUPAC Name: Not Available : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |